Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | CASP3 | P42574 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.31 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.31 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.31 |
| ▸ | NOS3 | P29474 | 1/20 | 0.31 |
| ▸ | NOS1 | P29475 | 1/20 | 0.31 |
| ▸ | NOS2 | P35228 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | MGLL | Q99685 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1673128 | 0.68 | — | — | |
| SCHEMBL21663873 | 0.65 | SMN1; SMN2 (0.34) | LMNASMN1; SMN2ALDH1A1MAPTATM | |
| SCHEMBL21664079 | 0.64 | KMT2A (0.41) | LMNASMN1; SMN2ALDH1A1MAPTNOS3 | |
| SCHEMBL21663793 | 0.64 | ALDH1A1 (0.38) | LMNASMN1; SMN2ALDH1A1MAPTATM | |
| SCHEMBL22471713 | 0.63 | NISCH (0.52) | LMNAALDH1A1 | |
| SCHEMBL21664135 | 0.62 | KDM4E (0.49) | LMNASMN1; SMN2ALDH1A1MAPTNPC1 | |
| SCHEMBL16766999 | 0.62 | LMNA (0.36) | LMNASMN1; SMN2MAPTNPC1RAB9A | |
| SCHEMBL27830670 | 0.61 | MMP12 (0.34) | SMN1; SMN2 | |
| SCHEMBL15843105 | 0.61 | ALDH1A1 (0.33) | LMNASMN1; SMN2ALDH1A1MAPTATM | |
| SCHEMBL21663870 | 0.61 | MAPT (0.48) | LMNASMN1; SMN2ALDH1A1MAPTATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116970019-A | Preparation method and application of novel steroid dihydro-pyrazole thiazoline derivative | 汕头大学医学院附属肿瘤医院 | 2023-10-31 | — | — | CN | disclosed |
| US-11319347-B2 | Peptide compound and method for producing same, composition for screening use, and method for selecting peptide compound | FUJIFILM CORPORATION (JP) | 2022-05-03 | — | — | US | disclosed |
| WO-2021162633-A1 | PREPARATION OF CATIONIC AND NEUTRAL FUSED N-HETEROCYCLES WITH OR WITHOUT ADDITIONAL HETEROATOMS | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2021-08-19 | — | — | WO | disclosed |
| US-20200040039-A1 | PEPTIDE COMPOUND AND METHOD FOR PRODUCING SAME, COMPOSITION FOR SCREENING USE, AND METHOD FOR SELECTING PEPTIDE COMPOUND | FUJIFILM CORPORATION (JP) | 2020-02-06 | — | — | US | disclosed |
| CN-101316516-B | Antimicrobial solutions and methods relating thereto | BYOCOAT ENTPR INC | 2012-05-30 | — | — | CN | disclosed |
| CN-102083313-A | Compositions and methods for reducing or preventing microorganism growth or survival in aqueous environments | BYOCOAT ENTPR INC | 2011-06-01 | — | — | CN | disclosed |
| CN-101316516-A | Antimicrobial solutions and methods relating thereto | BYOCOAT ENTPR INC (US) | 2008-12-03 | — | — | CN | disclosed |
| CN-1106386-C | Parasiticidal pyrazoles | PFIZER LTD (US) | 2003-04-23 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200040039-A1 | PEPTIDE COMPOUND AND METHOD FOR PRODUCING SAME, COMPOSITION FOR SCREENING USE, AND METHOD FOR SELECTING PEPTIDE COMPOUND | VIP, NPPA, NGLY1 | LMNA 3026/4885SMN1; SMN2 3728/4885ALDH1A1 4809/4885 |
| US-11319347-B2 | Peptide compound and method for producing same, composition for screening use, and method for selecting peptide compound | VIP, NPPA, NGLY1 | LMNA 3026/4885SMN1; SMN2 3728/4885ALDH1A1 4809/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.